Jiangsu Hetai Biotechnology

Jiangsu Hetai Biotechnology is a specialized medical technology company focused on the development and production of in vitro diagnostic (IVD) solutions. Headquartered in the China Medical City in Taizhou, the company primarily operates in the fields of molecular diagnostics and Point-of-Care Testing (POCT). Its core product line includes high-sensitivity PCR detection kits for infectious diseases, oncology markers, and genetic screening, alongside automated nucleic acid extraction systems. Hetai Biotechnology serves clinical laboratories, hospitals, and research institutions by providing integrated diagnostic workflows that emphasize accuracy and rapid turnaround times. The company maintains rigorous quality standards, including GMP and ISO certifications, to support its domestic and international commercial operations.